Tobira Therapeutics Completes Financing and Merger with Regado Biosciences
May 4, 2015Tobira (NASDAQ: TBRA) completes its merger with Regado Biosciences and has approx. $70M to advance cenicriviroc, which is being evaluated in Phase 2b clinical trial to treat NASH and liver fibrosis.
More »
Otonomy Announces FDA Acceptance of AuriPro(TM) New Drug Application
April 28, 2015Otonomy's New Drug Application for AuriPro to treat middle ear effusion in pediatric patients undergoing tympanostomy tube placement (TTP) surgery has been accepted for filing by the U.S. FDA.
More »
CoLucid Pharmaceuticals Announces Initiation of First Phase 3 Pivotal Trial of Lasmiditan in Migraine
April 28, 2015The first patient is randomized in CoLucid Pharmaceuticals' SAMURAI study, the Company's first Phase 3 pivotal trial evaluating lasmiditan for the treatment of migraines.
More »